Search research articles
Contact Us
Filters
Showing results (51-60 of 185) with videos related to
Page
of 19
Sort By:
European Journal of Haematology
|
November 18, 2014
Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation
Christof Scheid, Donna Reece, Meral Beksac, et al.
Acta Haematologica
|
April 1, 2015
Does low-molecular-weight heparin influence the antimyeloma effects of thalidomide? A retrospective analysis of data from the GIMEMA, Nordic and Turkish myeloma study groups
Meral Beksac, Anders Waage, Sara Bringhen, et al.
Blood Cancer Journal
|
March 22, 2022
Extramedullary disease in multiple myeloma: a systematic literature review
Joan Bladé, Meral Beksac, Jo Caers, et al.
Fetal and Pediatric Pathology
|
August 23, 2019
Fetal Cell Microchimerism; Normal and Immunocompromised Gestations in Mice
M Sinan Beksac, Erdem Fadiloglu, Ayse Nur Cakar, et al.
Balkan Medical Journal
|
March 24, 2023
Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center
Guldane Cengiz Seval, Sinem Civriz Bozdag, Selami Kocak Toprak, et al.
Cell Death & Disease
|
February 25, 2021
Suppression of steroid 5α-reductase type I promotes cellular apoptosis and autophagy via PI3K/Akt/mTOR pathway in multiple myeloma
Renjie Dou, Jinjun Qian, Wei Wu, et al.
Immunogenetics
|
September 18, 2021
A model integrating Killer Immunoglobulin-like Receptor (KIR) haplotypes for risk prediction of COVID-19 clinical disease severity
Meral Beksac, Hasan Yalim Akin, Emine Begum Gencer-Oncul, et al.
Leukemia Research
|
September 15, 2022
Evaluation of isatuximab in patients with soft-tissue plasmacytomas: An analysis from ICARIA-MM and IKEMA
Meral Beksac, Ivan Spicka, Roman Hajek, et al.
Journal of Hematology & Oncology
|
April 2, 2021
HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA
Fengjie Jiang, Xiaozhu Tang, Chao Tang, et al.
Expert Review of Anticancer Therapy
|
June 9, 2015
Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma
Paul G Richardson, Jacob P Laubach, Sagar Lonial, et al.
Page
of 19
Search research articles
Search
Showing results (51-60 of 185) with videos related to
Sort By:
Page
of 19
European Journal of Haematology
|
November 18, 2014
Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation
Christof Scheid, Donna Reece, Meral Beksac, et al.
Acta Haematologica
|
April 1, 2015
Does low-molecular-weight heparin influence the antimyeloma effects of thalidomide? A retrospective analysis of data from the GIMEMA, Nordic and Turkish myeloma study groups
Meral Beksac, Anders Waage, Sara Bringhen, et al.
Blood Cancer Journal
|
March 22, 2022
Extramedullary disease in multiple myeloma: a systematic literature review
Joan Bladé, Meral Beksac, Jo Caers, et al.
Fetal and Pediatric Pathology
|
August 23, 2019
Fetal Cell Microchimerism; Normal and Immunocompromised Gestations in Mice
M Sinan Beksac, Erdem Fadiloglu, Ayse Nur Cakar, et al.
Balkan Medical Journal
|
March 24, 2023
Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center
Guldane Cengiz Seval, Sinem Civriz Bozdag, Selami Kocak Toprak, et al.
Cell Death & Disease
|
February 25, 2021
Suppression of steroid 5α-reductase type I promotes cellular apoptosis and autophagy via PI3K/Akt/mTOR pathway in multiple myeloma
Renjie Dou, Jinjun Qian, Wei Wu, et al.
Immunogenetics
|
September 18, 2021
A model integrating Killer Immunoglobulin-like Receptor (KIR) haplotypes for risk prediction of COVID-19 clinical disease severity
Meral Beksac, Hasan Yalim Akin, Emine Begum Gencer-Oncul, et al.
Leukemia Research
|
September 15, 2022
Evaluation of isatuximab in patients with soft-tissue plasmacytomas: An analysis from ICARIA-MM and IKEMA
Meral Beksac, Ivan Spicka, Roman Hajek, et al.
Journal of Hematology & Oncology
|
April 2, 2021
HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA
Fengjie Jiang, Xiaozhu Tang, Chao Tang, et al.
Expert Review of Anticancer Therapy
|
June 9, 2015
Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma
Paul G Richardson, Jacob P Laubach, Sagar Lonial, et al.
Page
of 19